Victrex plc (LON:VCT – Get Free Report) insider Jane Toogood acquired 508 shares of the firm’s stock in a transaction that occurred on Tuesday, September 24th. The shares were purchased at an average price of GBX 937 ($12.55) per share, with a total value of £4,759.96 ($6,373.81).
Victrex Trading Up 0.6 %
LON VCT opened at GBX 932 ($12.48) on Wednesday. Victrex plc has a one year low of GBX 914.74 ($12.25) and a one year high of GBX 1,577 ($21.12). The company has a debt-to-equity ratio of 16.99, a current ratio of 5.30 and a quick ratio of 1.99. The firm has a market cap of £811.12 million, a P/E ratio of 2,662.86, a P/E/G ratio of 1.92 and a beta of 0.69. The stock’s 50-day moving average is GBX 1,019.22 and its 200-day moving average is GBX 1,168.51.
Analysts Set New Price Targets
Separately, Berenberg Bank reduced their price target on shares of Victrex from GBX 1,491 ($19.97) to GBX 1,290 ($17.27) and set a “hold” rating on the stock in a research report on Wednesday, August 28th.
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Read More
- Five stocks we like better than Victrex
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- 3 Small Caps With Big Return Potential
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.